PGNX - Progenics Pharmaceuticals' (PGNX) CEO David Mims on Q1 2020 Results - Earnings Call Transcript
Call Start: 8:30
Call End: 8:49
Progenics Pharmaceuticals, Inc. (PGNX)
Q1 2020 Earnings Conference Call
May 7, 2020 8:30 AM ET
Company Participants
Melissa Downs - Head, IR
Ann MacDougall - Interim Chair of the Board
David Mims - Interim CEO & CFO
Asha Das - CMO
Bryce Tenbarge - SVP, Commercial
Conference Call Participants
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Progenics Pharmaceuticals First Quarter 2020 Results Conference Call. At this time, all participants are in a listen-only mode. [Operator instructions].
I would now like to hand